Dexcom Inc (DXCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 769,600 | 696,200 | 628,800 | 698,200 | 650,200 |
| Cost of Goods | 275,400 | 246,700 | 230,700 | 225,600 | 203,300 |
| Gross Profit | 494,200 | 449,500 | 398,100 | 472,600 | 446,900 |
| Operating Expenses | 347,100 | 373,200 | 357,500 | 472,600 | 328,900 |
| Operating Income | 147,500 | 77,000 | 41,300 | 600 | 118,300 |
| Interest Expense | 0 | 4,700 | 4,600 | 0 | 4,600 |
| Other Income | -1,300 | 3,000 | -600 | 5,800 | -1,700 |
| Pre-tax Income | 146,200 | 75,300 | 36,100 | 6,400 | 112,000 |
| Income Tax | 45,000 | 24,400 | -61,200 | 11,700 | 24,700 |
| Net Income Continuous | 101,200 | 50,900 | 97,300 | -5,300 | 87,300 |
| Net Income | $101,200 | $50,900 | $97,300 | $-5,300 | $87,300 |
| EPS Basic Total Ops | 0.26 | 0.13 | 0.25 | -0.02 | 0.23 |
| EPS Basic Continuous Ops | 0.26 | 0.13 | 0.25 | -0.01 | 0.23 |
| EPS Diluted Total Ops | 0.24 | 0.12 | 0.23 | -0.01 | 0.21 |
| EPS Diluted Continuous Ops | 0.24 | 0.12 | 0.23 | -0.02 | 0.20 |
| EBITDA(a) | $186,700 | $120,600 | $78,100 | $32,700 | $143,800 |